MyDx (MYDX) Stock Price, News & Analysis

Company Overview

MyDx, Inc. is a science and technology company, which engages in the development and deployment of products and services in the areas of consumer products, data analytics, biopharmaceutical, and software as a service. Its product, MyDx, is a patented multiuse hand-held chemical analyzer designed to help consumers and professional test for pesticides in food, chemicals in water, toxins in the air, and safety and potency of cannabis samples. The company was founded by Daniel Rida Yazbeck on December 20, 2012 and is headquartered in San Diego, CA.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 900,000 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MYDX Stock Analysis - Frequently Asked Questions

How do I buy shares of MyDx?

Shares of MYDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of MyDx own?

Based on aggregate information from My MarketBeat watchlists, some other companies that MyDx investors own include Garb Oil & Power (GARB), Fluent (FLNT), Creative Edge Nutrition (FITX), Destination XL Group (DXLG), Cyber Apps World (CYAP), CurAegis Technologies (CRGS) and BioRestorative Therapies (BRTX).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Computer and Technology
• Industry: Scientific & Technical Instruments
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: OTCMKTS:MYDX
• CIK: 1582341
• Web: www.mydxlife.com
• Phone: (800) 814-4550
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A